Subsequently, a total of 22 differential metabolites based on the criteria of VIP>1, p<0.05, and FC>1.2 or FC<0.8 were determined between DM-ILD and DM-nonILD, of which seven were decreased and 15 were increased in DM-ILD group (Figure 3A). This evidence concerns the gene VIP and interstitial lung disease.